| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3295097 | Gastroenterology | 2009 | 15 Pages |
Abstract
These results suggest that Notch signaling is required for PDAC progression. Pharmacologic targeting of this pathway offers therapeutic potential in this treatment-refractory malignancy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ruben Plentz, Ji-Sun Park, Andrew D. Rhim, Daniel Abravanel, Aram F. Hezel, Sreenath V. Sharma, Sushma Gurumurthy, Vikram Deshpande, Candia Kenific, Jeffrey Settleman, Pradip K. Majumder, Ben Z. Stanger, Nabeel Bardeesy,